Clinical Trial Update: Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma

View source ↗

Summary

This completed study analyzes prognostic factors (clinical and biological) in patients with refractory or relapsed diffuse large B-cell lymphoma. Results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | Conditions: Diffuse Large B-cell Lymphoma | Status: COMPLETED | Results posted: 2016-04-18